Shares of Solventum Corp. SOLV rose 1.33% to $75.15 Monday, on what proved to be an all-around favorable trading session for ...

Solventum presently has a consensus price target of $79.86, suggesting a potential upside of 7.46%. As a group, “Surgical & medical instruments” companies have a potential upside of 31.83%.

Shares of Solventum Corp. SOLV slipped 2.31% to $72.30 Thursday, on what proved to be an all-around rough trading session for ...

Raymond James Financial Inc. bought a new position in shares of Solventum Co. (NYSE:SOLV – Free Report) in the 4th quarter, ...

Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: 14 March at 6:01:46 pm GMT-4 Loading Chart for SOLV ...